An Open-Label Study of YM087 Conivaptan in Patients With Euvolemic or Hypervolemic Hyponatremia Pages on BioPortfolio:

Results from other life science and pharmaceutical sites:

Untitled Document
Description of study: To evaluate the efficacy of oral conivaptan in patients with euvolemic or hypervolemic hyponatremia, the study enrolled 74 patients ...
http://www.hsc.wvu.edu/sop/wvcdhi/New%20Drug%20Monographs/Va...

Nature Clinical Practice Nephrology | Evaluation and management of ...
Figure 3 Effect of conivaptan (YM087) on least-squares mean plusminus ... In an open-label study of 104 patients with euvolemic hyponatremia, conivaptan was ...
http://www.nature.com/ncpneph/journal/v3/n2/full/ncpneph0401...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.